Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations - Concepedia

Concepedia

Publication | Open Access

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

DOI Full Paper Access

295

Citations

35

References

2018

Year

Fatima Karzai, David James VanderWeele, Ravi A. Madan, Helen Owens, Lisa M. Cordes, Amy Hankin, Anna Couvillon, E. Hitt Nichols, Marijo Bilušić, Michael L. Beshiri,

Journal for ImmunoTherapy of Cancer

Abstract

ClinicalTrials.gov identifier: NCT02484404 .

References

	Year	Citations

Page 1